Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Avertas - Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamuvidine compared to continued treatment with dolutegravir/abacavir/lamuvidine for virologically suppressed HIV infection: A randomized open-label superiority trial. AVERTAS-1 trial and AVETAS-2 trial

Project: Types of projectsProject

View graph of relations
StatusCurrent
Period01/09/2020 → …

ID: 67596838